Article Details

Roche receives FDA approval for VENTANA ALK (D5F3) CDx Assay to identify lung cancer ...

Retrieved on: 2021-03-09 06:00:00

Tags for this article:

Click the tags to see associated articles and topics

Roche receives FDA approval for VENTANA ALK (D5F3) CDx Assay to identify lung cancer .... View article details on hiswai:

Excerpt

This label expansion advances Roche's commitment to personalised healthcare by providing lung cancer patients with access to more treatment options ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up